CN Patent

CN113694019A — 短效苯基烷基胺钙通道阻滞剂的高水溶性盐及其应用

Assigned to Milestone Pharmaceuticals Inc · Expires 2021-11-26 · 4y expired

What this patent protects

本申请涉及短效苯基烷基胺钙通道阻滞剂的高水溶性盐及其应用。本发明包括令人惊讶的苯基烷基胺化合物的水溶性盐,其是L型钙通道的有效拮抗剂。包括本发明的盐的水溶液配制用于鼻给予并提供用于治疗稳定型心绞痛、偏头痛、和心律失常如阵发性室上性心动过速的新的治疗平台。

USPTO Abstract

本申请涉及短效苯基烷基胺钙通道阻滞剂的高水溶性盐及其应用。本发明包括令人惊讶的苯基烷基胺化合物的水溶性盐,其是L型钙通道的有效拮抗剂。包括本发明的盐的水溶液配制用于鼻给予并提供用于治疗稳定型心绞痛、偏头痛、和心律失常如阵发性室上性心动过速的新的治疗平台。

Drugs covered by this patent

Patent Metadata

Patent number
CN113694019A
Jurisdiction
CN
Classification
Expires
2021-11-26
Drug substance claim
No
Drug product claim
No
Assignee
Milestone Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.